Why the study?
Acute heart failure frequently presents to emergency departments with breathlessness, requiring clinical evaluation and biomarkers such as BNP, prompting evaluation of urinary density as a diagnostic biomarker.
Does urinary density measurement accurately diagnose acute heart failure compared to brain natriuretic peptide in patients presenting to the emergency department with breathlessness?
Does urinary density measurement accurately diagnose acute heart failure compared to brain natriuretic peptide in patients presenting to the emergency department with breathlessness?
Low urinary density (≤1.013) correlates negatively with BNP and demonstrates high sensitivity (91.18%) and specificity (80.82%) for diagnosing acute heart failure in emergency department patients presenting with breathlessness.
Answers are grounded in this paper and cite their sources.
Should not yet change ED practice for AHF diagnosis; leaves open urine density as a cheap BNP adjunct pending prospective multicenter validation.
Background: Heart failure (HF) has become a public healthcare concern with significant costs to countries because of the aging world population. Acute heart failure (AHF) is a common condition faced frequently in emergency departments, and patients often present to hospitals with complaints of breathlessness. The patient must be evaluated with anamnesis, physical examination, blood, and imaging results to diagnose AHF. Brain natriuretic peptide (BNP) is a widely accepted biomarker for the diagnosis of HF. Methods: The files of the patients who applied to the emergency department with complaints of breathlessness were scanned, and BNP and urinary density (UD) levels were evaluated for the diagnosis of HF in patients. Results: The results support that BNP is an effective biomarker in AHF, as is widely accepted. When the correlation between BNP and UD measurements was examined in the present study, a negative correlation was detected between the parameters. The results also suggested that low UD values may help diagnose AHF. Conclusion: If similar results are obtained in prospective multicenter studies with the participation of more patients, UD value can be used as a biomarker for the diagnosis of AHF.
No takes yet. Share an insight, caveat, or question.
Akçalı et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: